Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control

Allen Liao, N R Walker, Thomas J Carmody, Crystal Cooper Cortes, Meredith A Shaw, Bruce D. Grannemann, Phil Adams, Gerard E. Bruder, Melvin G. McInnis, Christian A. Webb, Daniel G. Dillon, Diego A. Pizzagalli, Mary L. Phillips, Benji T. Kurian, Maurizio Fava, Ramin V. Parsey, Patrick J. McGrath, Myrna M. Weissman, Madhukar H Trivedi

Research output: Contribution to journalArticle

Abstract

Background: Despite the fact that higher levels of anxiety and anhedonia in Major Depressive Disorder (MDD) are linked to poorer treatment outcomes, mechanisms contributing to these clinical presentations remain unclear. Neuroticism, impaired cognitive control, and blunted reward learning may be critical processes involved in MDD and may help to explain symptoms of anxiety and anhedonia. Methods: Using baseline data from patients with early-onset MDD (N = 296) in the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) trial, we conducted a path analysis to model relationships between neuroticism, cognitive control, and reward learning to levels of anxiety and anhedonia. Results: Neuroticism was positively associated with both anhedonia (standardized coefficient = 0.26, p <.001) and anxiety (standardized coefficient = 0.40, p <.001). Cognitive control was negatively associated with anxiety (standardized coefficient = -0.18, p <.05). Reward learning was not significantly associated with either anxiety or anhedonia. Limitations: Extraneous variables not included in the model may have even more influence in explaining symptoms of anxiety and anhedonia. Restricted range in these variables may have attenuated some of the hypothesized relationships. Most important, because this was a cross-sectional analysis in a currently depressed sample, we cannot draw any causal conclusions without experimental and longitudinal data. Conclusions: These cross-sectional findings suggest that neuroticism may contribute to anxiety and anhedonia in patients with early onset and either chronic or recurrent MDD, while enhanced cognitive control may protect against anxiety.

LanguageEnglish (US)
Pages1070-1078
Number of pages9
JournalJournal of Affective Disorders
Volume245
DOIs
StatePublished - Feb 15 2019

Fingerprint

Anhedonia
Anxiety
Depression
Major Depressive Disorder
Reward
Learning
Neuroticism
Antidepressive Agents
Cross-Sectional Studies
Clinical Trials

Keywords

  • Anhedonia
  • Anxiety
  • Cognitive control
  • Depression
  • Neuroticism

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Anxiety and anhedonia in depression : Associations with neuroticism and cognitive control. / Liao, Allen; Walker, N R; Carmody, Thomas J; Cooper Cortes, Crystal; Shaw, Meredith A; Grannemann, Bruce D.; Adams, Phil; Bruder, Gerard E.; McInnis, Melvin G.; Webb, Christian A.; Dillon, Daniel G.; Pizzagalli, Diego A.; Phillips, Mary L.; Kurian, Benji T.; Fava, Maurizio; Parsey, Ramin V.; McGrath, Patrick J.; Weissman, Myrna M.; Trivedi, Madhukar H.

In: Journal of Affective Disorders, Vol. 245, 15.02.2019, p. 1070-1078.

Research output: Contribution to journalArticle

Liao, A, Walker, NR, Carmody, TJ, Cooper Cortes, C, Shaw, MA, Grannemann, BD, Adams, P, Bruder, GE, McInnis, MG, Webb, CA, Dillon, DG, Pizzagalli, DA, Phillips, ML, Kurian, BT, Fava, M, Parsey, RV, McGrath, PJ, Weissman, MM & Trivedi, MH 2019, 'Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control', Journal of Affective Disorders, vol. 245, pp. 1070-1078. https://doi.org/10.1016/j.jad.2018.11.072
Liao, Allen ; Walker, N R ; Carmody, Thomas J ; Cooper Cortes, Crystal ; Shaw, Meredith A ; Grannemann, Bruce D. ; Adams, Phil ; Bruder, Gerard E. ; McInnis, Melvin G. ; Webb, Christian A. ; Dillon, Daniel G. ; Pizzagalli, Diego A. ; Phillips, Mary L. ; Kurian, Benji T. ; Fava, Maurizio ; Parsey, Ramin V. ; McGrath, Patrick J. ; Weissman, Myrna M. ; Trivedi, Madhukar H. / Anxiety and anhedonia in depression : Associations with neuroticism and cognitive control. In: Journal of Affective Disorders. 2019 ; Vol. 245. pp. 1070-1078.
@article{b53217a66bad4c6c81ca1f3bd2a9270e,
title = "Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control",
abstract = "Background: Despite the fact that higher levels of anxiety and anhedonia in Major Depressive Disorder (MDD) are linked to poorer treatment outcomes, mechanisms contributing to these clinical presentations remain unclear. Neuroticism, impaired cognitive control, and blunted reward learning may be critical processes involved in MDD and may help to explain symptoms of anxiety and anhedonia. Methods: Using baseline data from patients with early-onset MDD (N = 296) in the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) trial, we conducted a path analysis to model relationships between neuroticism, cognitive control, and reward learning to levels of anxiety and anhedonia. Results: Neuroticism was positively associated with both anhedonia (standardized coefficient = 0.26, p <.001) and anxiety (standardized coefficient = 0.40, p <.001). Cognitive control was negatively associated with anxiety (standardized coefficient = -0.18, p <.05). Reward learning was not significantly associated with either anxiety or anhedonia. Limitations: Extraneous variables not included in the model may have even more influence in explaining symptoms of anxiety and anhedonia. Restricted range in these variables may have attenuated some of the hypothesized relationships. Most important, because this was a cross-sectional analysis in a currently depressed sample, we cannot draw any causal conclusions without experimental and longitudinal data. Conclusions: These cross-sectional findings suggest that neuroticism may contribute to anxiety and anhedonia in patients with early onset and either chronic or recurrent MDD, while enhanced cognitive control may protect against anxiety.",
keywords = "Anhedonia, Anxiety, Cognitive control, Depression, Neuroticism",
author = "Allen Liao and Walker, {N R} and Carmody, {Thomas J} and {Cooper Cortes}, Crystal and Shaw, {Meredith A} and Grannemann, {Bruce D.} and Phil Adams and Bruder, {Gerard E.} and McInnis, {Melvin G.} and Webb, {Christian A.} and Dillon, {Daniel G.} and Pizzagalli, {Diego A.} and Phillips, {Mary L.} and Kurian, {Benji T.} and Maurizio Fava and Parsey, {Ramin V.} and McGrath, {Patrick J.} and Weissman, {Myrna M.} and Trivedi, {Madhukar H}",
year = "2019",
month = "2",
day = "15",
doi = "10.1016/j.jad.2018.11.072",
language = "English (US)",
volume = "245",
pages = "1070--1078",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Anxiety and anhedonia in depression

T2 - Journal of Affective Disorders

AU - Liao, Allen

AU - Walker, N R

AU - Carmody, Thomas J

AU - Cooper Cortes, Crystal

AU - Shaw, Meredith A

AU - Grannemann, Bruce D.

AU - Adams, Phil

AU - Bruder, Gerard E.

AU - McInnis, Melvin G.

AU - Webb, Christian A.

AU - Dillon, Daniel G.

AU - Pizzagalli, Diego A.

AU - Phillips, Mary L.

AU - Kurian, Benji T.

AU - Fava, Maurizio

AU - Parsey, Ramin V.

AU - McGrath, Patrick J.

AU - Weissman, Myrna M.

AU - Trivedi, Madhukar H

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Background: Despite the fact that higher levels of anxiety and anhedonia in Major Depressive Disorder (MDD) are linked to poorer treatment outcomes, mechanisms contributing to these clinical presentations remain unclear. Neuroticism, impaired cognitive control, and blunted reward learning may be critical processes involved in MDD and may help to explain symptoms of anxiety and anhedonia. Methods: Using baseline data from patients with early-onset MDD (N = 296) in the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) trial, we conducted a path analysis to model relationships between neuroticism, cognitive control, and reward learning to levels of anxiety and anhedonia. Results: Neuroticism was positively associated with both anhedonia (standardized coefficient = 0.26, p <.001) and anxiety (standardized coefficient = 0.40, p <.001). Cognitive control was negatively associated with anxiety (standardized coefficient = -0.18, p <.05). Reward learning was not significantly associated with either anxiety or anhedonia. Limitations: Extraneous variables not included in the model may have even more influence in explaining symptoms of anxiety and anhedonia. Restricted range in these variables may have attenuated some of the hypothesized relationships. Most important, because this was a cross-sectional analysis in a currently depressed sample, we cannot draw any causal conclusions without experimental and longitudinal data. Conclusions: These cross-sectional findings suggest that neuroticism may contribute to anxiety and anhedonia in patients with early onset and either chronic or recurrent MDD, while enhanced cognitive control may protect against anxiety.

AB - Background: Despite the fact that higher levels of anxiety and anhedonia in Major Depressive Disorder (MDD) are linked to poorer treatment outcomes, mechanisms contributing to these clinical presentations remain unclear. Neuroticism, impaired cognitive control, and blunted reward learning may be critical processes involved in MDD and may help to explain symptoms of anxiety and anhedonia. Methods: Using baseline data from patients with early-onset MDD (N = 296) in the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) trial, we conducted a path analysis to model relationships between neuroticism, cognitive control, and reward learning to levels of anxiety and anhedonia. Results: Neuroticism was positively associated with both anhedonia (standardized coefficient = 0.26, p <.001) and anxiety (standardized coefficient = 0.40, p <.001). Cognitive control was negatively associated with anxiety (standardized coefficient = -0.18, p <.05). Reward learning was not significantly associated with either anxiety or anhedonia. Limitations: Extraneous variables not included in the model may have even more influence in explaining symptoms of anxiety and anhedonia. Restricted range in these variables may have attenuated some of the hypothesized relationships. Most important, because this was a cross-sectional analysis in a currently depressed sample, we cannot draw any causal conclusions without experimental and longitudinal data. Conclusions: These cross-sectional findings suggest that neuroticism may contribute to anxiety and anhedonia in patients with early onset and either chronic or recurrent MDD, while enhanced cognitive control may protect against anxiety.

KW - Anhedonia

KW - Anxiety

KW - Cognitive control

KW - Depression

KW - Neuroticism

UR - http://www.scopus.com/inward/record.url?scp=85057444093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057444093&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.11.072

DO - 10.1016/j.jad.2018.11.072

M3 - Article

VL - 245

SP - 1070

EP - 1078

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -